AI-driven precision medicine market to hit $10b by 2032

This will be primarily driven by the integration of artificial intelligence in healthcare.

The global artificial intelligence (AI) in precision medicine market is projected to expand at a compound annual growth rate of around 31.35% from 2026 to 2032 to US$10.32, according to a MarkNtel Advisors report.

This will be primarily driven by the integration of artificial intelligence in healthcare, the rising demand for personalised treatment, and the growing adoption of genomics.

It is also being expanded by the growing role of AI in enhancing clinical decision-making and drug discovery processes.

Despite the strong growth outlook, the market faces challenges, including privacy and security concerns and high implementation costs.

The use of sensitive patient data in AI-driven systems also raises significant concerns regarding data protection, regulatory compliance, and ethical considerations.